Vaccines against mucosal infections

Current Opinion in Immunology
Jan Holmgren, Ann-Mari Svennerholm

Abstract

There remains a great need to develop vaccines against many of the pathogens that infect mucosal tissues or have a mucosal port of entry. Parenteral vaccination may protect in some instances, but usually a mucosal vaccination route is necessary. Mucosal vaccines also have logistic advantages over injectable vaccines by being easier to administer, having less risk of transmitting infections and potentially being easier to manufacture. Still, however, only relatively few vaccines for human use are available: oral vaccines against cholera, typhoid, polio, and rotavirus, and a nasal vaccine against influenza. For polio, typhoid and influenza, in which the pathogens reach the blood stream, there is also an injectable vaccine alternative. A problem with available oral live vaccines is their reduced immunogenicity when used in developing countries; for instance, the efficacy of rotavirus vaccines correlates closely with the national per capita income. Research is needed to define the impact of factors such as malnutrition, aberrant intestinal microflora, concomitant infections, and preexisting immunity as well as of host genetic factors on the immunogenicity of these vaccines.

References

May 1, 1981·The Journal of Infectious Diseases·A M SvennerholmB Svennerholm
Sep 4, 1999·Lancet·A SinhaM K Bhan
Feb 24, 2001·The New England Journal of Medicine·T V MurphyUNKNOWN Rotavirus Intussusception Investigation Team
Apr 26, 2001·The New England Journal of Medicine·F Y LinS C Szu
Dec 13, 2003·Vaccine·Yash Paul
Feb 25, 2005·The New England Journal of Medicine·Marcelino E S LucasJohn D Clemens
Mar 9, 2005·Emerging Infectious Diseases·W Abdullah BrooksRobert F Breiman
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Jan 6, 2006·The New England Journal of Medicine·Timo VesikariUNKNOWN Rotavirus Efficacy and Safety Trial (REST) Study Team
Feb 24, 2006·Emerging Infectious Diseases·Umesh D ParasharRoger I Glass
Aug 6, 2008·Vaccine·Marie-Claude Bonnet, Anil Dutta
Jun 6, 2009·JAMA : the Journal of the American Medical Association·Manish PatelUmesh Parashar
Jul 25, 2009·The New England Journal of Medicine·Dipika SurJohn D Clemens
Aug 15, 2009·Epidemiology and Infection·A K SiddiqueR B Sack
Jan 29, 2010·The New England Journal of Medicine·Shabir A MadhiKathleen M Neuzil
May 15, 2010·Lancet·Robert E BlackUNKNOWN Child Health Epidemiology Reference Group of WHO and UNICEF
May 21, 2010·Vaccine·UNKNOWN WHO Publication
Jun 17, 2010·BMJ : British Medical Journal·Orbelina de PalmaManish Patel
Aug 13, 2010·The Journal of Infectious Diseases·Richard L WardPaul A Offit
Aug 13, 2010·The Journal of Infectious Diseases·Robert PawinskiHtay Htay Han
Mar 29, 2011·Critical Reviews in Microbiology·Shengqiang Ge, Zhiliang Wang
Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Zindoga MukandavireJ Glenn Morris
Jul 29, 2011·The New England Journal of Medicine·Beryl P GladstoneGagandeep Kang
Oct 13, 2011·Expert Review of Vaccines·Pearay L OgraRoland W Sutter
Oct 29, 2011·The Lancet Infectious Diseases·Michael T OsterholmEdward A Belongia

❮ Previous
Next ❯

Citations

Feb 28, 2013·The British Journal of Nutrition·Shelly N HesterSharon M Donovan
Apr 23, 2013·Applied and Environmental Microbiology·James A GregoryStephen Mayfield
Dec 19, 2013·PloS One·Elena PettiniDonata Medaglini
Aug 22, 2013·World Journal of Gastroenterology : WJG·Sheila K JacobiJack Odle
Mar 15, 2014·Experimental & Molecular Medicine·Sae-Hae Kim, Yong-Suk Jang
May 30, 2014·The New England Journal of Medicine·Francisco J LuqueroRebecca F Grais
Jan 18, 2014·The Journal of Infectious Diseases·Robin UchiyamaAndrew T Gewirtz
Aug 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Calman A MacLennan, Allan Saul
Oct 24, 2014·Immunotherapy·Gil Reynolds Diogo, Rajko Reljic
May 9, 2015·Expert Opinion on Drug Delivery·Yimei JiaAbdelwahab Omri
Jun 10, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Heleen KraanJean-Pierre Amorij
Oct 21, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kim BaertBert Devriendt
Mar 31, 2015·Advanced Drug Delivery Reviews·Christopher J H Davitt, Ed C Lavelle
Feb 26, 2016·Expert Review of Vaccines·Heleen KraanJean-Pierre Amorij
Jun 4, 2014·Reviews in Medical Virology·Laura Hertel
Jan 7, 2015·Veterinary Research·Igor KolotilinRima Menassa
Jan 30, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Atul SrivastavaMeenakshi Iyer
Jun 19, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jamie F S MannRobin J Shattock
Jun 13, 2013·Seminars in Immunology·Calman A MacLennan
May 6, 2014·Current Opinion in Virology·Kejian Yang, Steven M Varga
Sep 7, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Claudia ZilkerVladimir Temchura
Oct 16, 2014·Memórias do Instituto Oswaldo Cruz·Renata Monteiro-Maia, Rosa Teixeira de Pinho
May 17, 2018·Revista Da Sociedade Brasileira De Medicina Tropical·Karis Maria de Pinho Rodrigues, Beatriz Meurer Moreira
Jul 6, 2013·The Cochrane Database of Systematic Reviews·Tanvir AhmedFirdausi Qadri
Nov 1, 2016·Journal of Bacteriology·Bhupender SinghMagnus Andersson
Nov 17, 2016·Clinical and Vaccine Immunology : CVI·Katayi MwilaSylvia Becker-Dreps

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.